As of June 2026, 1 paid clinical trial is recruiting for Metabolic syndrome in New Brunswick, New Jersey. Recruiting Metabolic syndrome studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
New Brunswick has approximately 366 recruiting research studies across a wide range of therapeutic areas. New Jersey hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Researchers run research studies in New Brunswick, NJ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Rutgers Cancer Institute of New Jersey | Breast Cancer, Acute Myeloid Leukemia, Multiple Myeloma | 124 |
| Rutgers Cancer Institute | Acute Myeloid Leukemia, Anal Cancer, Breast Cancer | 27 |
| Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital | B Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ganglioneuroblastoma, Nodular | 24 |
| Saint Peter's University Hospital | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia | 23 |
| Rutgers Robert Wood Johnson Medical School | Opioid Use, Acute Otitis Media, Aortic Stenosis, Calcific | 18 |
| Robert Wood Johnson University Hospital | Aortic Valve Stenosis, AMI, ASD - Atrial Septal Defect | 15 |
| Rutgers University | Advanced Breast Cancer, Aneurysm, Brain, Anxiety | 12 |
| Robert Wood Johnson Medical School | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 9 |
| RWJBarnabas Health - Robert Wood Johnson University Hospital | Cervical Cancer, Anal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma | 7 |
| Rutgers | Aortoiliac Occlusive Disease, Breast Neoplasms, Carcinoma, Ductal, Breast | 4 |
| Rutgers - Robert Wood Johnson Medical School | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 4 |
| Rutgers Cancer Institute of New Jersey ( Site 0033) | Breast Neoplasms, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostate Cancer Metastatic | 4 |
| Cancer Institute of New Jersey | Anxiety, Caregiver Stress Syndrome, Metastases, Neoplasm | 3 |
| GSK Investigational Site | Asthma, Neoplasms, Scleroderma, Systemic | 3 |
| Rutgers, Robert Wood Johnson Medical School | Alzheimer Disease, Asthma, Chronic Pseudomonas Aeruginosa Infection | 3 |
| Rutgers, The State University of New Jersey | Cervical Cancer, Coagulation Disorder, Papilloma Viral Infection | 3 |
| Saint Peter's University Hospital - New Brunswick- Site Number : 840016 | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 3 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| Clinical Trial Site | Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL), Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL), Transthyretin Amyloidosis With Cardiomyopathy | 2 |
| Cooperman Barnabas Medical Center | Breast Cancer, Metastatic Breast Cancer, Metastatic Non Small Cell Lung Cancer | 2 |
| Rutgers Cancer Institute of NJ | Advanced Solid Malignancies, Endometrial Adenocarcinoma | 2 |
| Rutgers Cancer Institute of New Jersey ( Site 0052) | Breast Cancer, Breast Neoplasms, Malignant Neoplasm | 2 |
| Rutgers Health | Pancreatic Cystic Lesions, Triple Negative Breast Cancer | 2 |
| Rutgers University (Data Collection Only) | Hepatectomy, Malignant Mesothelioma, Malignant Peritoneal Mesothelioma | 2 |
| Rutgers-Robert Wood Johnson Medical School | Amyloid Cardiomyopathy, Amyloidosis, Cardiogenic Shock | 2 |
Recruiting trials in New Brunswick grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in New Jersey are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. New Jersey research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in New Brunswick from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 366 recruiting clinical trials in New Brunswick, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in New Brunswick compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in New Brunswick include Breast Cancer (17), Acute Myeloid Leukemia (11), Cancer (7), Multiple Myeloma (7), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New Brunswick on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in New Brunswick include Rutgers Cancer Institute of New Jersey, Rutgers Cancer Institute, Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in New Brunswick are Cancer & tumors (192), Neurology & pain (14), Cardiovascular (13). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.